Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.
Clinical trial NCT03325296 · TERMINATED
Trial details
- NCT number
- NCT03325296
- Sponsor
- LEO Pharma
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-30
- Primary completion
- 2018-05-16
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.